Cathie Wood’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $495M | Buy |
10,182,590
+17,190
|
|
||||
|
2025
Q1 | $346M | Buy |
10,165,400
+1,192,336
|
|
||||
|
2024
Q4 | $353M | Buy |
8,973,064
+1,474,439
|
|
||||
|
2024
Q3 | $352M | Sell |
7,498,625
-279,911
|
|
||||
|
2024
Q2 | $420M | Sell |
7,778,536
-378,492
|
|
||||
|
2024
Q1 | $556M | Sell |
8,157,028
-379,076
|
|
||||
|
2023
Q4 | $534M | Buy |
8,536,104
+1,372,986
|
|
||||
|
2023
Q3 | $325M | Sell |
7,163,118
-175,329
|
|
||||
|
2023
Q2 | $412M | Sell |
7,338,447
-651,741
|
|
||||
|
2023
Q1 | $361M | Buy |
7,990,188
+160,256
|
|
||||
|
2022
Q4 | $318M | Sell |
7,829,932
-407,190
|
|
||||
|
2022
Q3 | $538M | Sell |
8,237,122
-1,490,409
|
|
||||
|
2022
Q2 | $565M | Buy |
9,727,531
+323,460
|
|
||||
|
2022
Q1 | $590M | Buy |
9,404,071
+316,203
|
|
||||
|
2021
Q4 | $689M | Buy |
9,087,868
+1,502,194
|
|
||||
|
2021
Q3 | $849M | Sell |
7,585,674
-190,445
|
|
||||
|
2021
Q2 | $1.26B | Sell |
7,776,119
-514,231
|
|
||||
|
2021
Q1 | $1.01B | Sell |
8,290,350
-2,122,626
|
|
||||
|
2020
Q4 | $1.59B | Buy |
10,412,976
+1,955,656
|
|
||||
|
2020
Q3 | $707M | Buy |
8,457,320
+1,974,069
|
|
||||
|
2020
Q2 | $476M | Buy |
6,483,251
+2,197,619
|
|
||||
|
2020
Q1 | $182M | Buy |
4,285,632
+1,328,997
|
|
||||
|
2019
Q4 | $180M | Buy |
2,956,635
+174,495
|
|
||||
|
2019
Q3 | $114M | Buy |
2,782,140
+57,791
|
|
||||
|
2019
Q2 | $128M | Buy |
2,724,349
+701,332
|
|
||||
|
2019
Q1 | $72.3M | Buy |
2,023,017
+697,907
|
|
||||
|
2018
Q4 | $37.9M | Sell |
1,325,110
-128,480
|
|
||||
|
2018
Q3 | $64.5M | Buy |
1,453,590
+986,450
|
|
||||
|
2018
Q2 | $27.4M | Buy |
467,140
+394,606
|
|
||||
|
2018
Q1 | $3.32M | Buy |
72,534
+41,146
|
|
||||
|
2017
Q4 | $737K | Buy |
31,388
+5,833
|
|
||||
|
2017
Q3 | $457K | Buy |
25,555
+12,667
|
|
||||
|
2017
Q2 | $206K | Buy |
+12,888
|
|